chr16-71284506-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018348.6(CMTR2):c.1415G>T(p.Gly472Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,756 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018348.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CMTR2 | NM_018348.6 | c.1415G>T | p.Gly472Val | missense_variant | 3/3 | ENST00000434935.7 | NP_060818.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CMTR2 | ENST00000434935.7 | c.1415G>T | p.Gly472Val | missense_variant | 3/3 | 1 | NM_018348.6 | ENSP00000411148.2 | ||
CMTR2 | ENST00000338099.9 | c.1415G>T | p.Gly472Val | missense_variant | 3/3 | 1 | ENSP00000337512.5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 250144Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135524
GnomAD4 exome AF: 0.0000253 AC: 37AN: 1461580Hom.: 0 Cov.: 34 AF XY: 0.0000303 AC XY: 22AN XY: 727054
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74336
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.1415G>T (p.G472V) alteration is located in exon 3 (coding exon 1) of the CMTR2 gene. This alteration results from a G to T substitution at nucleotide position 1415, causing the glycine (G) at amino acid position 472 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at